Effects of Alendronate on Cartilage Lesions and Micro-architecture Deterioration of Subchondral Bone in Patellofemoral Osteoarthritic Ovariectomized Rats with Patella-baja

Overview

Journal J Orthop Surg Res

Publisher Biomed Central

Specialty Orthopedics

Date 2024 Mar 26

PMID 38528611

Authors

Mingjian Bei

Zhiyuan Zheng

Yaping Xiao

Ning Liu

Xuehui Cao

Faming Tian

Liu Zhang

Xinbao Wu

Affiliations

Soon will be listed here.

Abstract

Background: Patellofemoral osteoarthritis (PFJOA) is a subtype of knee OA, which is one of the main causes of anterior knee pain. The current study found an increased prevalence of OA in postmenopausal women, called postmenopausal OA. Therefore, we designed the ovariectomized rat model of patella baja-induced PFJOA. Alendronate (ALN) inhibits osteoclast-mediated bone loss, and has been reported the favorable result of a potential intervention option of OA treatment. However, the potential effects of ALN treatment on PFJOA in the ovariectomized rat model are unknown and need further investigation prior to exploration in the clinical research setting. In this study, the effects of ALN on articular cartilage degradation and subchondral bone microstructure were assessed in the ovariectomized PFJOA rat model for 10 weeks.

Methods: Patella baja and estrogen withdrawal were induced by patellar ligament shortening (PLS) and bilateral ovariectmomy surgeries in 3-month-old female Sprague-Dawley rats, respectively. Rats were randomly divided into five groups (n = 8): Sham + V; OVX + V, Sham + PLS + V, OVX + PLS + V, OVX + PLS + ALN (ALN: 70 μg/kg/week). Radiography was performed to evaluate patellar height ratios, and the progression of PFJOA was assessed by macroscopic and microscopic analyses, immunohistochemistry and micro-computed tomography (micro-CT).

Results: Our results found that the patella baja model prepared by PLS can successfully cause degeneration of articular cartilage and subchondral bone, resulting in changes of PFJOA. OVX caused a decrease in estrogen levels in rats, which aggravated the joint degeneration caused by PFJOA. Early application of ALN can delay the degenerative changes of articular cartilage and subchondral bone microstructure in castrated PFJOA rat to a certain extent, improve and maintain the micrometabolism and structural changes of cartilage and subchondral bone.

Conclusion: The early application of ALN can delay the destruction of articular cartilage and subchondral bone microstructure in castrated PFJOA rat to a certain extent.

Citing Articles

Incidence of Total Knee Arthroplasty in Older Females with Knee Osteoarthritis and Osteoporosis Treated with Denosumab Compared with Those Treated Using Bisphosphonates: A Population-Based Cohort Study.

Yu T, Wu W, Lee R, Chen I, Wang J, Wen S Life (Basel). 2025; 14(12.

PMID: 39768410 PMC: 11677198. DOI: 10.3390/life14121704.

References

Randsborg P, Aroen A, Owesen C . The Effect of Lesion Size on Pain and Function in Patients Scheduled for Cartilage Surgery of the Knee. Cartilage. 2022; 13(2):19476035221109242. PMC: 9277437. DOI: 10.1177/19476035221109242. View

Mankin H, DORFMAN H, Lippiello L, Zarins A . Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am. 1971; 53(3):523-37. View

Papathanasiou I, Michalitsis S, Hantes M, Vlychou M, Anastasopoulou L, Malizos K . Molecular changes indicative of cartilage degeneration and osteoarthritis development in patients with anterior cruciate ligament injury. BMC Musculoskelet Disord. 2016; 17:21. PMC: 4712525. DOI: 10.1186/s12891-016-0871-8. View

Dye S . The pathophysiology of patellofemoral pain: a tissue homeostasis perspective. Clin Orthop Relat Res. 2005; (436):100-10. DOI: 10.1097/01.blo.0000172303.74414.7d. View

Chen K, Zhang N, Ding L, Zhang W, Hu J, Zhu S . Early intra-articular injection of alendronate reduces cartilage changes and subchondral bone loss in rat temporomandibular joints after ovariectomy. Int J Oral Maxillofac Surg. 2014; 43(8):996-1004. DOI: 10.1016/j.ijom.2014.04.003. View

van Jonbergen H, Scholtes V, Poolman R . A randomised, controlled trial of circumpatellar electrocautery in total knee replacement without patellar resurfacing: a concise follow-up at a mean of 3.7 years. Bone Joint J. 2014; 96-B(4):473-8. DOI: 10.1302/0301-620X.96B4.32118. View

Migliorini F, Baroncini A, Bell A, Weber C, Hildebrand F, Maffulli N . Surgical strategies for chondral defects of the patellofemoral joint: a systematic review. J Orthop Surg Res. 2022; 17(1):524. PMC: 9720953. DOI: 10.1186/s13018-022-03419-4. View

Varady N, Grodzinsky A . Osteoarthritis year in review 2015: mechanics. Osteoarthritis Cartilage. 2015; 24(1):27-35. PMC: 4693146. DOI: 10.1016/j.joca.2015.08.018. View

Arceo-Mendoza R, Camacho P . Postmenopausal Osteoporosis: Latest Guidelines. Endocrinol Metab Clin North Am. 2021; 50(2):167-178. DOI: 10.1016/j.ecl.2021.03.009. View

10.

Guingamp C, Gegout-Pottie P, Philippe L, Terlain B, Netter P, Gillet P . Mono-iodoacetate-induced experimental osteoarthritis: a dose-response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum. 1997; 40(9):1670-9. DOI: 10.1002/art.1780400917. View

11.

Bellido M, Lugo L, Roman-Blas J, Castaneda S, Caeiro J, Dapia S . Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis. Arthritis Res Ther. 2010; 12(4):R152. PMC: 2945051. DOI: 10.1186/ar3103. View

12.

Xin F, Wang H, Yuan F, Ding Y . Platelet-Rich Plasma Combined with Alendronate Reduces Pain and Inflammation in Induced Osteoarthritis in Rats by Inhibiting the Nuclear Factor-Kappa B Signaling Pathway. Biomed Res Int. 2020; 2020:8070295. PMC: 7539111. DOI: 10.1155/2020/8070295. View

13.

Cheng T, Zhang L, Fu X, Wang W, Xu H, Song H . The potential protective effects of calcitonin involved in coordinating chondrocyte response, extracellular matrix, and subchondral trabecular bone in experimental osteoarthritis. Connect Tissue Res. 2013; 54(2):139-46. DOI: 10.3109/03008207.2012.760549. View

14.

Yang X, Yan K, Zhang Q, Yusufu A, Ran J . Meta-Analysis of Estrogen in Osteoarthritis: Clinical Status and Protective Effects. Altern Ther Health Med. 2022; 29(1):224-230. View

15.

Panahifar A, Maksymowych W, Doschak M . Potential mechanism of alendronate inhibition of osteophyte formation in the rat model of post-traumatic osteoarthritis: evaluation of elemental strontium as a molecular tracer of bone formation. Osteoarthritis Cartilage. 2012; 20(7):694-702. DOI: 10.1016/j.joca.2012.03.021. View

16.

Theocharis A, Skandalis S, Gialeli C, Karamanos N . Extracellular matrix structure. Adv Drug Deliv Rev. 2015; 97:4-27. DOI: 10.1016/j.addr.2015.11.001. View

17.

Zhang M, Wang Y, Huan Z, Liu Y, Zhang W, Kong D . FSH modulated cartilage ECM metabolism by targeting the PKA/CREB/SOX9 pathway. J Bone Miner Metab. 2021; 39(5):769-779. DOI: 10.1007/s00774-021-01232-3. View

18.

Findlay D, Atkins G . Osteoblast-chondrocyte interactions in osteoarthritis. Curr Osteoporos Rep. 2014; 12(1):127-34. PMC: 3933767. DOI: 10.1007/s11914-014-0192-5. View

19.

Acibadem E, Keskinruzgar A, Bozdag Z, Yavuz G . Therapeutic effect of alendronate in an experimental temporomandibular joint osteoarthritis. J Oral Rehabil. 2022; 50(2):113-121. DOI: 10.1111/joor.13396. View

20.

Safiri S, Kolahi A, Smith E, Hill C, Bettampadi D, Mansournia M . Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017. Ann Rheum Dis. 2020; 79(6):819-828. DOI: 10.1136/annrheumdis-2019-216515. View